血清素2A受体 (5-HT2AR) 激动剂:幻觉药和非幻觉类同类作为新兴抗抑郁药
Wenwen Duan1, Dongmei Cao2, Sheng Wang2,3
1iHuman Institute, ShanghaiTech University, 393 Middle Huaxia Road, Shanghai 201210, China.
Chemical reviews
|November 30, 2023
概括
迷幻药通过激活血清素2A受体 (5-HT2AR) 来显示出作为抗抑郁药的前景. 研究重点是设计更安全的,非幻觉的5-HT2AR激动剂,以改善抑郁症治疗.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
- 药用化学 医学化学
背景情况:
- 迷幻药,如 псилоцибин,是激活血清素2A受体 (5-HT2AR) 的精神活性化合物.
- 临床试验表明,传统的迷幻药具有快速起作用和持久的抗抑郁药物特性.
- 需要合理设计的5-HT2AR激动剂,具有优化的药理资料,以增强治疗潜力和减少幻觉效应.
研究的目的:
- 为现有的5-HT2AR激动剂提供结构-活性关系 (SAR) 的概述.
- 讨论在结构层面上了解5-HT2AR激动剂的分子药理学的最新进展.
- 探索开发具有改善亚型选择性和信号偏差的新型5-HT2AR激应剂,以获得更安全的抗抑郁药物应用.
主要方法:
- 对当前5-HT2AR激动剂的化学分类和SAR的审查.
- 对5-HT2AR激动剂的最新结构和分子药理学数据的分析.
- 讨论基于结构的药物设计和功能选择性选方法.
主要成果:
- 现有的5-HT2AR激动剂表现出基于化学结构的多种SAR.
- 结构生物学方面的进步提供了对5-HT2AR-连接体相互作用的见解.
- 药物发现正在向具有增强选择性和信号偏差的新型激动剂取得进展.
结论:
- 新的5-HT2AR激动剂具有作为更安全,非幻觉性抗抑郁药的潜力.
- 基于结构的设计和功能选择性是开发改进的基于迷幻的治疗方法的关键策略.
- 进一步的研究可以加速发现优化的5-HT2AR激动剂用于抑郁症治疗.
更多相关视频
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
8.9K
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
544
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
01:22CNS Stimulants: Psychedelic Agents
156
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
156
01:25Antidepressant Drugs: Overview
511
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
511
01:27Hallucinogens and Psychedelics
175
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
175
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
401
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
401
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
266
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
266